Skip to content
Bomb Report – Lifestyle
Author:
Ensysce Biosciences
Ensysce Biosciences Announces First Peer-Reviewed Clinical Publication Demonstrating Oral Overdose Protection with MPAR(R) Technology
March 6, 2026
Ensysce Biosciences Initiates Review of Strategic Alternatives to Enhance Shareholder Value
March 5, 2026
←
Previous Page
1
2